insights_auto
Why is MRK up 2.26%?
Dive Deeperchevron_right
MRK:NYSE
Merck & Co Inc
$145.60
arrow_upward
+2.26%(+3.22) 1D
Oct 9, 4:02:34 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRK...
Open
$141.37
High
$146.68
Low
$141.36
Mkt. cap
359.22B
Avg. vol.
9.40M
Volume
0.00
Dividend
2.34%
Quarterly dividend
$0.85
Ex-dividend date
Sep 15, 2026
P/E ratio
116.29
52-wk high
$156.92
52-wk low
$82.01
EPS
$1.25
Beta
0.21
Shares outstanding
2.47B
No. of employees
74K
Open
$141.37
High
$146.68
Low
$141.36
Mkt. cap
359.22B
Avg. vol.
9.40M
Volume
0.00
Dividend
2.34%
Quarterly dividend
$0.85
Ex-dividend date
Sep 15, 2026
P/E ratio
116.29
52-wk high
$156.92
52-wk low
$82.01
EPS
$1.25
Beta
0.21
Shares outstanding
2.47B
No. of employees
74K
News stories
From web sources and news partners
Kalkine Media
·
49 minutes ago
Can a Heart-Drug Trial Give Merck (NYSE:MRK) Post-Blockbuster Hope?
Simply Wall Street
·
2 hours ago
Merck (MRK) Posts One Year Remigromig Data Matching Standard Eye Therapy
GuruFocus
·
14 hours ago
Merck's Experimental Eye Drug Shows Promise Amid Safety Concerns, Ticker MRK
Seeking Alpha
·
14 hours ago
Merck's experimental eye drug meets goal in trial, but raises safety concerns (MRK:NYSE)
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com